SEC Form 4 · accession 0000899243-16-035579
Teladoc Health, Inc. · TDOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Dec 13, 2016
Accepted (ET)
Dec 15, 2016 · 10:10 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001477449
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 13, 2016 | S | 176,000 | $16.59 | D | 4,804,468 | D | |
| Common StockF3,F2 | Dec 14, 2016 | S | 324,000 | $16.23 | D | 4,480,468 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.10 to $16.85, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
- F2CHP III Management, L.L.C.(the "GP") is the sole General Partner of CHP III, L.P. John K. Clarke, Brandon H. Hull and John J. Park (collectively, the "Managing Members") are Managing Members of the GP, and, as such, may be deemed to have shared voting and dispositive power with respect to the issuer's securities held of CHP III, L.P. (the "CHP III Shares"). Each of the GP and the Managing Members disclaims beneficial ownership of the CHP III Shares, except to the extent of their respective pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the shares for purposes of Section 16 or for any other purpose.
- F3Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.10 to $16.55, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.